Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6

Bernard Klein, XG Zhang, M Jourdan, +5

Blood

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia

Bernard Klein, John Wijdenes, XG Zhang, +7

Blood

Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma

XG Zhang, JP Gaillard, N Robillard, +6

Blood

Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma

XG Zhang, Bernard Klein, Régis Bataille

Blood

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.

Bernard Klein, XG Zhang, M Jourdan, +6

PubMed

Hematological MalignancyTumor BiologyCytokineAutoimmune DiseaseMalignant Blood Disorder +13

Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells [see comments]

XG Zhang, R Bataille, M Jourdan, +4

Blood

Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells

Lu Zy, XG Zhang, Carmen Rodríguez, +7

Blood

gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL- 6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro

M Portier, XG Zhang, Émilie Caron, +3

Blood

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6

Bernard Klein, XG Zhang, M Jourdan, +5

Blood

Relationship between blood glucose fluctuation and macrovascular endothelial dysfunction in type 2 diabetic patients with coronary heart disease.

XG Zhang, Yingqi Zhang, D-K Zhao, +5

PubMed